Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detemir vs NPH for T2DM in Pregnancy
NCT03620890Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Sep 2018
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by UTHealth Houston. Primary endpoint: Number of Neonates With Composite Adverse Neonatal Outcome. Started Sep 2018; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03620890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620890.